PMI patients with the PCSK6 CA + AA genotype have milder coronary stenosis, partially because they have higher ApoA1/ApoB levels; patients with the PCSK6 CA + AA genotype have a better long-term prognosis, partially because they have lower TC/HDL levels and are less likely to have TVD. This evidence concerns the gene APOA1 and coronary stenosis.